๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thromboembolism

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement NCT04258488Phase 416 sites๐Ÿ“ Bucheon-si๐Ÿ“ Busan๐Ÿ“ Daegu Joon Bum Kim ยท Tests: Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin) Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients NCT06357403n/a3 sites๐Ÿ“ Graz๐Ÿ“ Innsbruck๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Anti-factor Xa activity calibrated for enoxaparin Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters NCT05029063Phase 311 sites๐Ÿ“ Halifax๐Ÿ“ Brampton๐Ÿ“ Hamilton Ottawa Hospital Research Institute ยท Tests: Rivaroxaban 10 MG START-Register: Survey on Anticoagulated Patients Register NCT02219984n/a1 site๐Ÿ“ Bologna GUALTIERO PALARETI ยท Tests: Anticoagulants CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention NCT07575867n/a1 site๐Ÿ“ Moscow National Medical Research Center for Therapy and Preventiveโ€ฆ ยท Tests: Left Atrial Appendage Closure, Apixaban 2.5 mg BID, Standard-dose DOAC Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury NCT05484557NA1 site๐Ÿ“ Raanana Loewenstein Hospital ยท Tests: Apixaban, Enoxaparin Sodium Filter Initial & Long Term Evaluation After Placement and Retrieval Registry NCT01158482n/a1 site๐Ÿ“ Stanford Stanford University ยท Tests: IVC Filter Placement or Retrieval Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplasty NCT07869615NA1 site๐Ÿ“ Tunis Military Hospital of Tunis ยท Tests: Apixaban, Rivaroxaban, Enoxaparin (LMWH) Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer NCT07288632n/a1 site๐Ÿ“ Perugia University Of Perugia Sulodexide, VESSELยฎ, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) NCT04257487Phase 31 site๐Ÿ“ Rozzano Arianna Anticoagulazione Foundation ยท Tests: Sulodexide, Sulodexide and placebo, Placebo Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study NCT05089227Phase 21 site๐Ÿ“ Dijon Centre Hospitalier Universitaire Dijon ยท Tests: treatment "intervention", treatment "standard", biological assessment Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery NCT06657924Phase 21 site๐Ÿ“ Cleveland Kristen Ban ยท Tests: Tranexamic acid Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery NCT07439991n/a1 site๐Ÿ“ Changchun The First Hospital of Jilin University ยท Tests: Prospective Perioperative Data Collection The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs NCT06806540n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Cancer-related Venous Thromboembolic Disease - Cohort Study NCT06393764n/a1 site๐Ÿ“ Brest University Hospital, Brest ยท Tests: Collection of biological samples High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC) NCT07166731n/a1 site๐Ÿ“ Solingen Acandis GmbH Statins to Prevent Cancer Associated Blood Clots NCT07303816Phase 49 sites๐Ÿ“ Irvine๐Ÿ“ New Haven๐Ÿ“ Miami Brigham and Women's Hospital ยท Tests: Rosuvastatin, Placebo Drug Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study NCT05881798n/a7 sites๐Ÿ“ Los Angeles๐Ÿ“ Barcelona๐Ÿ“ Cรณrdoba Cook Research Incorporated ยท Tests: Celect Platinum Vena Cava Filter The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion NCT05490901n/a1 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: Exercise hemodynamic test Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM) NCT07813377n/a1 site๐Ÿ“ Barcelona Fundacion Clinic per a la Recerca Biomรฉdica ยท Tests: Thromboelastometry values: EXTEM CT, MCF, ฮฑ-angle below the lower limit of normal. Measurement obtained after anesthetiโ€ฆ Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis NCT06958588Phase 41 site๐Ÿ“ Belo Horizonte Science Valley Research Institute ยท Tests: Experimental: Hyperslim, Active Comparator #1 Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage NCT06753786NA1 site๐Ÿ“ Moscow Pirogov Russian National Research Medical University ยท Tests: Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the firsโ€ฆ Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) NCT03728166NA1 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Electronic alert Personalized Anticoagulant Therapy for Pulmonary Thromboembolism NCT06341231n/a1 site๐Ÿ“ Changsha Xiangya Hospital of Central South University Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients NCT07856641n/a1 site๐Ÿ“ Houston The University of Texas Health Science Center, Houston Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention NCT07243080Phase 41 site๐Ÿ“ Lahore Mayo Hospital Lahore ยท Tests: rivaroxaban (10mg), Enoxaparin 40 mg SC PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) NCT03559114Phase 312 sites๐Ÿ“ Calgary๐Ÿ“ Edmonton๐Ÿ“ Edmonton Sunnybrook Health Sciences Centre ยท Tests: Dalteparin, Saline inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT NCT06581965Phase 413 sites๐Ÿ“ Apeldoorn๐Ÿ“ Geleen๐Ÿ“ Geldrop Leiden University Medical Center ยท Tests: Short duration prophylaxis, Higher intensity and longer duration prophylaxis, Control The Erlanger Stroke Registry (ESPro) is the Only Ongoing Prospective Population-based Stroke Registry in Germany, Started in 1994. ESPro Includes All Hospitalized and Non-hospitalized Patients With Stroke in the Community of Erlangen (120.000 Inhabitants), With a Long-life Follow-up. NCT07771335n/a3 sites๐Ÿ“ Erlangen๐Ÿ“ Erlangen๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School Heat Shock Protein 47 in Thrombosis NCT06731673n/a2 sites๐Ÿ“ Aarhus๐Ÿ“ Berlin University of Aarhus
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy